100%(17)17 out of 17 people found this document helpful
This preview shows page 1 - 3 out of 5 pages.
1Decision Tree for Alzheimer’s DiseaseKristin Mercer, RN BSNWalden UniversityNURS 6521N-27 Advanced PharmacologyApril 18, 2020
2Decision Tree for Alzheimer’s DiseaseAlzheimer disease (AD) an irreversible neurological disease (Rosenthal, 2018). Characteristics of AD include progressive memory loss, impaired thinking, inability to perform daily task of living and neuropsychiatric symptoms (Rosenthal, 2018). Drugs are utilized to help relieve symptoms, slow memory loss, and prolong independence (Rosenthal, 2018). The purposeof this paper is to briefly summarize the patient case study including each of the three decisions you took, explain whether the decisions provided were supported by the evidence-based literature, state what I was hoping to achieve, and explain the difference between what I expectedto achieve with each of the decisions and the results of the decision in the exercise.Patient Case Study SummaryIn this specific case study Mr. Akkad is a 76-year old who has presented to the office where his son reports “strange behavior” over the last couple of years. While assessing the patient a Mini-Mental State Exam is performed indicating moderate dementia (Laureate Education, 2019). The diagnosis for this patient is major neurocognitive disorder due to Alzheimer’s disease (presumptive) (Laureate Education, 2019). As for the decision tree the first decision point I decided to begin Aricept 5mg by mouth at bedtime. After four weeks the patient returns to the clinic with no improvements (Laureate Education, 2019). For the second decision point I decide to increase Aricept to 10 mg by mouth at bedtime. After four weeks the patient returns to the clinic where the son reports that the patient